U.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use
Data from Pfizer’s clinical trial showed two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in high-risk patients
Data from Pfizer’s clinical trial showed two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in high-risk patients